Developer of sustainable cell-free enzyme technology pursuing uses that include active ingredients for nutraceuticals and pharmaceuticals, CEO Michael Heltzen tell GEN Edge
GEN Edge: What’s in a Name - Out with Invizyne, In with eXoZymes
0:12
GEN Edge: What’s in a Name - Out with Invizyne, In with eXoZymes
Monrovia, CA -- May 16, 2025 -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of...